CATEGORIES

Pharmaceutics

LATEST

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

The Covid Global Clinical Trials for mRNA. Thank You for Participating

There are more than one hundred ways an RNA molecule can be chemically modified after it is synthesized. The functions of many of these...

Unravelling the Dangers of mRNA With Genomics

All the discussions centering around the mRNA Covid shots miss one fundamental point in their haste to point to either all the possible side...